Home › NDC Lookup › RxCUI directory › RxCUI 2586427

Topiramate 25 MG/ML Oral Solution — RxCUI 2586427

RxNorm drug concept · Semantic clinical drug
RxCUI 2586427 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2586427
Official nameTopiramate 25 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped9
Reported Medicaid activity (SDUD)24,566 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Topiramate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
📖 Read our full Topiramate guide →

🕸️ Concept Web — How Topiramate 25 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Topiramate 25 MG/ML Oral Solution RxCUI 2586427

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Topiramate 38404
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Eprontia 2586428
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Topiramate Oral Solution 2586426
    • Topiramate Oral Liquid Product 2586425
    • Topiramate Oral Product 1162749
    • Topiramate Oral Solution [Eprontia] 2586432
    • Eprontia Oral Liquid Product 2586431
    • Eprontia Oral Product 2586430
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Topiramate 25 MG/ML SCDC · 2586424
  • Topiramate Oral Solution SCDF · 2586426
  • Topiramate Oral Liquid Product SCDG · 2586425
  • Topiramate Oral Product SCDG · 1162749

Brand-Name Concepts

  • Topiramate 25 MG/ML Oral Solution [Eprontia] SBD · 2586433
  • Topiramate 25 MG/ML [Eprontia] SBDC · 2586429
  • Topiramate Oral Solution [Eprontia] SBDF · 2586432
  • Eprontia Oral Liquid Product SBDG · 2586431
  • Eprontia Oral Product SBDG · 2586430
  • Eprontia BN · 2586428

📦 FDA Products & Package NDCs

4 products · 9 package NDCs
9 package NDCs map to RxCUI 2586427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52652-9001-01 473 mL in 1 BOTTLE (52652-9001-1) Eprontia Azurity Pharmaceuticals, Inc. 2021-12-06
52652-9001-02 1 BOTTLE in 1 CARTON (52652-9001-2) / 240 mL in 1 BOTTLE Eprontia Azurity Pharmaceuticals, Inc. 2023-01-02
52652-9001-03 1 BOTTLE in 1 CARTON (52652-9001-3) / 120 mL in 1 BOTTLE Eprontia Azurity Pharmaceuticals, Inc. 2023-01-02
67877-0833-47 473 mL in 1 BOTTLE (67877-833-47) TOPIRAMATE Ascend Laboratories, LLC 2025-07-07
67877-0833-61 1 BOTTLE in 1 CARTON (67877-833-61) / 120 mL in 1 BOTTLE TOPIRAMATE Ascend Laboratories, LLC 2025-07-07
67877-0833-67 1 BOTTLE in 1 CARTON (67877-833-67) / 240 mL in 1 BOTTLE TOPIRAMATE Ascend Laboratories, LLC 2025-07-07
81033-0035-14 10 CUP, UNIT-DOSE in 1 CARTON (81033-035-14) / 4 mL in 1 CU... TOPIRAMATE Kesin Pharma 2026-07-01
81033-0035-15 10 CUP, UNIT-DOSE in 1 CARTON (81033-035-15) / 6 mL in 1 CU... TOPIRAMATE Kesin Pharma 2026-07-01
81033-0035-16 10 CUP, UNIT-DOSE in 1 CARTON (81033-035-16) / 8 mL in 1 CU... TOPIRAMATE Kesin Pharma 2026-07-01
Observed labelers: Ascend Laboratories, LLC (3) · Azurity Pharmaceuticals, Inc. (3) · Kesin Pharma (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$2.0740
Range $1.0902–$2.7023 · middle 50% $1.5794–$2.5545 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.